RPS6KA3 and Coffin-Lowry syndrome: RSK2-mediated p53 phosphorylation is confirmed by the in vitro kinase assay and Western blot analysis using leukemia cells obtained from patients, who have normal RSK2 genetic allele and RSK2 deficient CLS patients (13).